Cyclic Adenosine Monophosphate–Independent Tyrosine Phosphorylation of NR2B Mediates Cocaine-Induced Extracellular Signal-Regulated Kinase Activation

[1]  H. Oppermann,et al.  Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src). , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Greengard,et al.  DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1 , 1984, Nature.

[3]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M E Greenberg,et al.  Stimulation of protein tyrosine phosphorylation by NMDA receptor activation , 1991, Science.

[5]  J. Glowinski,et al.  Somatostatin potentiates the alpha 1-adrenergic activation of phospholipase C in striatal astrocytes through a mechanism involving arachidonic acid and glutamate. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Girault,et al.  Stimulation of protein-tyrosine phosphorylation in rat striatum after lesion of dopamine neurons or chronic neuroleptic treatment. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Lefkowitz,et al.  Functionally active targeting domain of the beta-adrenergic receptor kinase: an inhibitor of G beta gamma-mediated stimulation of type II adenylyl cyclase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Huganir,et al.  Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions , 1995, Neuroreport.

[9]  G. Landwehrmeyer,et al.  NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  S. Berger,et al.  Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: Studies on the involvement of dopamine , 1997, Synapse.

[11]  T. Chase,et al.  Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration , 1998, Brain Research.

[12]  C. Cepeda,et al.  Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. , 1998, Journal of neurophysiology.

[13]  P. Greengard,et al.  A Dopamine/D1 Receptor/Protein Kinase A/Dopamine- and cAMP-Regulated Phosphoprotein (Mr 32 kDa)/Protein Phosphatase-1 Pathway Regulates Dephosphorylation of the NMDA Receptor , 1998, The Journal of Neuroscience.

[14]  P. Redgrave,et al.  The basal ganglia: a vertebrate solution to the selection problem? , 1999, Neuroscience.

[15]  M. Sheng,et al.  Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. , 1999, Science.

[16]  D. Jane,et al.  Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites. , 2000, The Journal of pharmacology and experimental therapeutics.

[17]  P. Greengard,et al.  Regulation of Phosphorylation of the GluR1 AMPA Receptor in the Neostriatum by Dopamine and Psychostimulants In Vivo , 2000, The Journal of Neuroscience.

[18]  M. Besson,et al.  Involvement of the Extracellular Signal-Regulated Kinase Cascade for Cocaine-Rewarding Properties , 2000, The Journal of Neuroscience.

[19]  R. Malenka,et al.  Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. , 2000, Annual review of neuroscience.

[20]  Eric J. Nestler,et al.  Molecular basis of long-term plasticity underlying addiction , 2001, Nature Reviews Neuroscience.

[21]  J. Girault,et al.  Gαolf is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum , 2001, Journal of neurochemistry.

[22]  J. Angulo,et al.  Comparison of Cocaine‐ and Methamphetamine‐Evoked Dopamine and Glutamate Overflow in Somatodendritic and Terminal Field Regions of the Rat Brain during Acute, Chronic, and Early Withdrawal Conditions , 2001, Annals of the New York Academy of Sciences.

[23]  D. Standaert,et al.  Dopamine D1 Receptor-Dependent Trafficking of Striatal NMDA Glutamate Receptors to the Postsynaptic Membrane , 2001, The Journal of Neuroscience.

[24]  A. Fienberg,et al.  Gαolf Levels Are Regulated by Receptor Usage and Control Dopamine and Adenosine Action in the Striatum , 2001, The Journal of Neuroscience.

[25]  H. Ueno,et al.  Requirement of Ras for the Activation of Mitogen-Activated Protein Kinase by Calcium Influx, cAMP, and Neurotrophin in Hippocampal Neurons , 2001, The Journal of Neuroscience.

[26]  A. Fienberg,et al.  DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens , 2002, Nature Neuroscience.

[27]  Paul Greengard,et al.  Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32. , 2002, Journal of neurophysiology.

[28]  C. Gerfen,et al.  D1 Dopamine Receptor Supersensitivity in the Dopamine-Depleted Striatum Results from a Switch in the Regulation of ERK1/2/MAP Kinase , 2002, The Journal of Neuroscience.

[29]  Angus C. Nairn,et al.  NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling , 2003, Nature Neuroscience.

[30]  Shiaoching Gong,et al.  A gene expression atlas of the central nervous system based on bacterial artificial chromosomes , 2003, Nature.

[31]  Yehezkel Ben-Ari,et al.  The NMDA Receptor Is Coupled to the ERK Pathway by a Direct Interaction between NR2B and RasGRF1 , 2003, Neuron.

[32]  R. Lefkowitz,et al.  PKA-mediated phosphorylation of the beta1-adrenergic receptor promotes Gs/Gi switching. , 2004, Cellular signalling.

[33]  Michael W. Salter,et al.  Src kinases: a hub for NMDA receptor regulation , 2004, Nature Reviews Neuroscience.

[34]  David G Standaert,et al.  Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. , 2004, Molecular pharmacology.

[35]  J. Girault,et al.  Addictive and non‐addictive drugs induce distinct and specific patterns of ERK activation in mouse brain , 2004, The European journal of neuroscience.

[36]  B. H. Shah,et al.  GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences , 2004, Trends in Neurosciences.

[37]  L. Luttrell,et al.  Not so strange bedfellows: G-protein-coupled receptors and Src family kinases , 2004, Oncogene.

[38]  A. Kelley.  Memory and Addiction Shared Neural Circuitry and Molecular Mechanisms , 2004, Neuron.

[39]  J. Girault,et al.  Parsing Molecular and Behavioral Effects of Cocaine in Mitogen- and Stress-Activated Protein Kinase-1-Deficient Mice , 2005, The Journal of Neuroscience.

[40]  S. Russo,et al.  Cocaine induction of ERK proteins in dorsal striatum of Fischer rats. , 2005, Brain research. Molecular brain research.

[41]  Angus C Nairn,et al.  Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Henze,et al.  Clozapine Potentiation of N-Methyl-d-aspartate Receptor Currents in the Nucleus Accumbens: Role of NR2B and Protein Kinase A/Src Kinases , 2005, Journal of Pharmacology and Experimental Therapeutics.

[43]  P. Greengard,et al.  Regulation of NMDA receptor trafficking by amyloid-β , 2005, Nature Neuroscience.

[44]  K. Neve,et al.  Modulation of D2R-NR2B Interactions in Response to Cocaine , 2006, Neuron.

[45]  S. Hyman,et al.  Neural mechanisms of addiction: the role of reward-related learning and memory. , 2006, Annual review of neuroscience.

[46]  Qin Wang,et al.  Arrestin Serves as a Molecular Switch, Linking Endogenous α2-Adrenergic Receptor to SRC-dependent, but Not SRC-independent, ERK Activation* , 2006, Journal of Biological Chemistry.

[47]  C. Cepeda,et al.  Where Do You Think You Are Going? The NMDA-D1 Receptor Trap , 2006, Science's STKE.

[48]  Anish Arora,et al.  Phosphorylation of glutamate receptors: A potential mechanism for the regulation of receptor function and psychostimulant action , 2006, Journal of neuroscience research.

[49]  Y. Shaham,et al.  Role of ERK in cocaine addiction , 2006, Trends in Neurosciences.

[50]  David G Standaert,et al.  Dopamine D1 Activation Potentiates Striatal NMDA Receptors by Tyrosine Phosphorylation-Dependent Subunit Trafficking , 2006, The Journal of Neuroscience.

[51]  L. Mao,et al.  Regulation of mitogen‐activated protein kinases by glutamate receptors , 2007, Journal of neurochemistry.

[52]  C. Pagès,et al.  A TAT–DEF–Elk-1 Peptide Regulates the Cytonuclear Trafficking of Elk-1 and Controls Cytoskeleton Dynamics , 2007, The Journal of Neuroscience.

[53]  C. Pike,et al.  Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons. , 2007, Cellular signalling.

[54]  Denis Hervé,et al.  ERK2: a logical AND gate critical for drug-induced plasticity? , 2007, Current opinion in pharmacology.

[55]  F. Gao,et al.  Dopamine D1 and D3 receptors oppositely regulate NMDA‐ and cocaine‐induced MAPK signaling via NMDA receptor phosphorylation , 2007, Journal of neurochemistry.

[56]  Denis Hervé,et al.  Quantitative Changes in Gαolf Protein Levels, but not D1 Receptor, Alter Specifically Acute Responses to Psychostimulants , 2007, Neuropsychopharmacology.

[57]  J. Horvitz,et al.  Dopaminergic Mechanisms in Actions and Habits , 2007, The Journal of Neuroscience.

[58]  Jisheng Han,et al.  NR2B-containing NMDA receptor is required for morphine-but not stress-induced reinstatement , 2007, Experimental Neurology.

[59]  Gilberto Fisone,et al.  Parkinson's disease: Levodopa‐induced dyskinesia and signal transduction , 2008, The FEBS journal.

[60]  V. Quiñones-Jenab,et al.  Effects of dopamine and NMDA receptors on cocaine-induced Fos expression in the striatum of Fischer rats , 2008, Brain Research.

[61]  P. Greengard,et al.  Dichotomous Dopaminergic Control of Striatal Synaptic Plasticity , 2008, Science.

[62]  J. Girault,et al.  Opposing Patterns of Signaling Activation in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons in Response to Cocaine and Haloperidol , 2008, The Journal of Neuroscience.

[63]  R. Yaka,et al.  Prolonged Withdrawal from Repeated Noncontingent Cocaine Exposure Increases NMDA Receptor Expression and ERK Activity in the Nucleus Accumbens , 2009, The Journal of Neuroscience.

[64]  C. Papasian,et al.  Stability of NMDA receptors at the plasma membrane controls synaptic and behavioral adaptations to amphetamine , 2009, Nature Neuroscience.

[65]  Emmanuel Roze,et al.  Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse , 2009, Journal of neurochemistry.

[66]  J. A. Varela,et al.  D1/D5 Modulation of Synaptic NMDA Receptor Currents , 2009, The Journal of Neuroscience.

[67]  Tommaso Pizzorusso,et al.  Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) Controls Activation of Extracellular Signal-Regulated Kinase (ERK) Signaling in the Striatum and Long-Term Behavioral Responses to Cocaine , 2009, Biological Psychiatry.

[68]  Yvette E. Fisher,et al.  Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids , 2010, The European journal of neuroscience.

[69]  Paul Greengard,et al.  Mechanisms of Locomotor Sensitization to Drugs of Abuse in a Two-Injection Protocol , 2010, Neuropsychopharmacology.